Percutaneous coronary intervention in the elderly

Kully Sandhu1, Sunil K Nadar2

  • 1Royal Stoke Hospital, University Hospitals of North Midlands, Newcastle Road, Stoke on Trent ST46QG, United Kingdom.

Insights

Older adults are increasingly experiencing heart conditions like acute coronary syndrome. Percutaneous coronary intervention (PCI) offers significant benefits for this high-risk group, improving prognosis and quality of life.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Interventional Cardiology

Background:

  • Population demographics show a rising number of octogenarians and older individuals.
  • This demographic shift leads to an increased incidence of acute coronary syndrome and stable angina in older patients.
  • Older patients often present with a higher burden of coronary disease and more comorbidities compared to younger populations.

Purpose of the Study:

  • To review current trials and studies on percutaneous coronary intervention (PCI) in octogenarians.
  • To highlight the benefits of PCI in older adults, including improved prognosis, symptomatic relief, and quality of life.
  • To identify future research directions for optimizing PCI in the elderly population.

Main Methods:

  • Review of retrospective and prospective studies focusing on PCI in octogenarians.
  • Analysis of existing literature on the outcomes of percutaneous coronary intervention in elderly patients.
  • Synthesis of data from trials that increasingly include the "real" elderly population.

Main Results:

  • Octogenarians represent a high-risk group for both elective and emergency PCI procedures.
  • Despite increased risk, older adults stand to gain the most from PCI in terms of prognosis and quality of life.
  • Existing studies, though historically excluding this group, now show significant potential benefits.

Conclusions:

  • Recognizing and risk-stratifying elderly patients who can benefit most from PCI is a critical new frontier.
  • Future developments should focus on assessing frailty, encouraging early presentation, addressing gender differences, identifying culprit lesions, and minimizing vascular complications.
  • Percutaneous coronary intervention holds significant promise for improving outcomes and quality of life in the elderly population with coronary artery disease.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
586
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
325
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
469
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
813